These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20691212)

  • 1. Repertoire of antibodies against type 1 poliovirus in human sera.
    Rezapkin G; Neverov A; Cherkasova E; Vidor E; Sarafanov A; Kouiavskaia D; Dragunsky E; Chumakov K
    J Virol Methods; 2010 Nov; 169(2):322-31. PubMed ID: 20691212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.
    Ivanov AP; Dragunsky EM
    Expert Rev Vaccines; 2005 Apr; 4(2):167-72. PubMed ID: 15889990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
    Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
    Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [German Health survey 1997/98: immune status against poliomyelitis].
    Diedrich S; Claus H; Thierfelder W; Bellach BM; Schreier E
    Dtsch Med Wochenschr; 2000 May; 125(19):584-8. PubMed ID: 11320716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
    Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].
    Li CG; Ying ZF; Wang JF; Fang HH; Li YP; Li RC; Bonnet MC; Zhang YP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):501-3. PubMed ID: 19950717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus neutralizing antibody persistence after vaccination with the Sabin vaccine: a follow-up study.
    Farisano G; Trivello R; Moschen ME; Bonello C; Baldo V; Moretti G; Majori S; Marin F; Piron L; Renzulli G
    Ann Clin Lab Sci; 1995; 25(2):200-6. PubMed ID: 7785968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
    Herremans MM; Reimerink JH; Ras A; Van Der Avoort HG; Kimman TG; Van Loon AM; Conyn-Van Spaendonck MA; Koopmans MP
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):659-64. PubMed ID: 9384285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative selection on neutralization epitopes of poliovirus surface proteins: implications for prediction of candidate epitopes for immunization.
    Suzuki Y
    Gene; 2004 Mar; 328():127-33. PubMed ID: 15019992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.